Download PDF
Klinische Neurophysiologie 2010; 41(2): 106-115
DOI: 10.1055/s-0030-1248408
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Frühdiagnose der möglichen Alzheimer-Erkrankung anhand neuer Forschungskriterien

Early Diagnosis of Probable Alzheimer's Disease (AD) Based on New Research CriteriaN.  G.  Müller1 , 2 , D.  Bittner1
  • 1Universitätsklinik für Neurologie, Otto-von-Guericke-Universität
  • 2Deutsches Zentrum für Neurodegenerative Erkrankungen, Magdeburg
Further Information

Publication History

Publication Date:
24 June 2010 (online)

Also available at
    Permissions and Reprints

Lernziele

Kenntnisse über

Schwierigkeiten und Notwendigkeit der frühzeitigen Diagnose einer Alzheimer-Erkrankung Forschungskriterien zur Diagnose im Prodromalstadium der Alzheimer-Erkrankung Möglichkeiten und Grenzen der Forschungskriterien

Literatur

  • 1 Dubois B. et al . Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.  Lancet Neurol. 2007;  6 734-746
    CrossrefPubMedSearch in Google Scholar
  • 2 McKhann G. et al . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.  Neurology. 1984;  34 939-944
    CrossrefPubMedSearch in Google Scholar
  • 3 Gilman S. et al . Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.  Neurology. 2005;  64 1553-1562
    CrossrefPubMedSearch in Google Scholar
  • 4 Peterse R C. Mild cognitive impairment as a diagnostic entity.  J Intern Med. 2004;  256 183-194
    CrossrefPubMedSearch in Google Scholar
  • 5 Petersen R C. et al . Mild cognitive impairment: clinical characterization and outcome.  Arch Neurol. 1999;  56 303-308
    CrossrefPubMedSearch in Google Scholar
  • 6 Feldman H H. et al . Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.  Lancet Neurol. 2007;  6 501-512
    CrossrefPubMedSearch in Google Scholar
  • 7 Petersen R C. et al . Vitamin E and donepezil for the treatment of mild cognitive impairment.  N Engl J Med. 2005;  352 2379-2388
    CrossrefPubMedSearch in Google Scholar
  • 8 Winblad B. et al . Safety and efficacy of galantamine in subjects with mild cognitive impairment.  Neurology. 2008;  70 2024-2035
    CrossrefPubMedSearch in Google Scholar
  • 9 Thal L J. et al . A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.  Neuropsychopharmacology. 2005;  30 1204-1215
    CrossrefPubMedSearch in Google Scholar
  • 10 Förstl H. et al . [MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods].  Dtsch Med Wochenschr. 2009;  134 88-91
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Jicha G A. et al . Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.  Arch Neurol. 2006;  63 674-681
    CrossrefPubMedSearch in Google Scholar
  • 12 Varma A R. et al . Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.  J Neurol Neurosurg Psychiatry. 1999;  66 184-188
    CrossrefPubMedSearch in Google Scholar
  • 13 Buschke H. et al . Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity.  Neurology. 1997;  48 989-997
    PubMedSearch in Google Scholar
  • 14 Jack Jr C R. et al . Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.  Neurology. 2002;  58 750-757
    PubMedSearch in Google Scholar
  • 15 Deweer B. et al . Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI.  J Neurol Neurosurg Psychiatry. 1995;  58 590-597
    CrossrefPubMedSearch in Google Scholar
  • 16 de Leon M J. et al . Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.  Neurobiol Aging. 2006;  27 394-401
    CrossrefPubMedSearch in Google Scholar
  • 17 Scheltens P. et al . Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.  Lancet Neurol. 2002;  1 13-21
    CrossrefPubMedSearch in Google Scholar
  • 18 Bottino C M. et al . Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.  Int Psychogeriatr. 2002;  14 59-72
    CrossrefPubMedSearch in Google Scholar
  • 19 Visser P J. et al . Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.  J Neurol. 1999;  246 477-485
    CrossrefPubMedSearch in Google Scholar
  • 20 Visser P J. et al . Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.  J Neurol Neurosurg Psychiatry. 2002;  72 491-497
    PubMedSearch in Google Scholar
  • 21 Dickerson B C. et al . MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease.  Neurobiol Aging. 2001;  22 747-754
    CrossrefPubMedSearch in Google Scholar
  • 22 Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease.  Lancet Neurol. 2003;  2 605-613
    CrossrefPubMedSearch in Google Scholar
  • 23 Hansson O. et al . Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study.  Lancet Neurol. 2006;  5 228-234
    CrossrefPubMedSearch in Google Scholar
  • 24 Peskind E R. et al . Safety and acceptability of the research lumbar puncture.  Alzheimer Dis Assoc Disord. 2005;  19 220-225
    CrossrefPubMedSearch in Google Scholar
  • 25 Patwardhan M B. et al . Alzheimer disease: operating characteristics of PET--a meta-analysis.  Radiology. 2004;  231 73-80
    CrossrefPubMedSearch in Google Scholar
  • 26 Minoshima S. et al . Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.  Ann Neurol. 2001;  50 358-365
    CrossrefPubMedSearch in Google Scholar
  • 27 Koeppe R A. et al . 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.  J Nucl Med. 2005;  46 936-944
    PubMedSearch in Google Scholar
  • 28 Anchisi D. et al . Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.  Arch Neurol. 2005;  62 1728-1733
    CrossrefPubMedSearch in Google Scholar
  • 29 Klunk W E. et al . Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B.  Ann Neurol. 2004;  55 306-319
    CrossrefPubMedSearch in Google Scholar
  • 30 Fagan A M. et al . Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.  Ann Neurol. 2006;  59 512-519
    CrossrefPubMedSearch in Google Scholar
  • 31 Shoghi-Jadid K. et al . Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.  Am J Geriatr Psychiatry. 2002;  10 24-35
    PubMedSearch in Google Scholar
  • 32 Mintun M A. et al . [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.  Neurology. 2006;  67 446-452
    CrossrefPubMedSearch in Google Scholar
  • 33 Dougall N J, Bruggink S, Ebmeier K P. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia.  Am J Geriatr Psychiatry. 2004;  12 554-570
    Search in Google Scholar
  • 34 O’Brien J T. et al . Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.  Arch Neurol. 2004;  61 919-925
    CrossrefPubMedSearch in Google Scholar
  • 35 Borroni B. et al . Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.  Neurobiol Aging. 2006;  27 24-31
    CrossrefPubMedSearch in Google Scholar
  • 36 Huang C. et al . Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.  Neurobiol Aging. 2007;  28 1062-1069
    CrossrefPubMedSearch in Google Scholar
  • 37 Kung M P. et al . Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.  Eur J Nucl Med Mol Imaging. 2004;  31 1136-1145
    PubMedSearch in Google Scholar
  • 38 Galton C J. et al . Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.  Brain. 2000;  123 484-498
    CrossrefPubMedSearch in Google Scholar
  • 39 Luck T. et al . Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe).  Dement Geriatr Cogn Disord. 2007;  24 307-316
    CrossrefPubMedSearch in Google Scholar

PD Dr. med. Notger Müller

Universitätsklinik für Neurologie und Deutsches Zentrum für Neurodegenerative Erkrankungen

Leipziger Straße 44

39120 Magdeburg

Email: notger.mueller@med.ovgu.de